Factor (median [IQR]) | Q1 | Q2 | Q3 | Q4 | P value |
---|---|---|---|---|---|
2.16–3.78 % | 3.86–4.95 % | 4.96–6.37 % | 6.39–13.2 % | ||
n = 31 | n = 30 | n = 31 | n = 30 |  | |
Endostatin (ng/mL) | 136.75 [83.51, 198.57] | 134.87 [103.91, 191.11] | 109.08 [83.17, 184.55] | 118.38 [92.03, 150.14] | 0.50 |
ADMA (μmol/L) | 0.47 [0.40, 0.54] | 0.43 [0.40, 0.51] | 0.47 [0.41, 0.50] | 0.48 [0.44, 0.56] | 0.57 |
Thrombospondin-2 (pg/mL) | 20,900.0 [14,800.0, 26,500.0] | 21,000.0 [15,400.0, 33,000.0] | 19,100.0 [15,200.0, 26,300.0] | 26,000.0 [16,450.0, 33,900.0] | 0.45 |
Endoglin (ng/mL), mean ± SD | 4.43 ± 1.49 | 4.50 ± 1.08 | 3.91 ± 0.84 | 4.47 ± 1.23 | 0.18 |
Angiopoietin-2 (ng/mL) | 2.08 [1.50, 3.11] | 2.75 [1.51, 4.48] | 2.45 [1.47, 4.86] | 2.23 [1.71, 4.44] | 0.79 |